Michael Matson

Stock Analyst at Needham

(2.62)
# 2,053
Out of 5,112 analysts
23
Total ratings
69.23%
Success rate
11.46%
Average return

Stocks Rated by Michael Matson

Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408$423
Current: $125.10
Upside: +238.13%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $6.82
Upside: +1,219.65%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $87.23
Upside: -39.24%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $85.06
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $245.94
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $94.48
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $63.08
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $352.58
Upside: -
Mobileye Global
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $10.11
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $74.93
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $88.98
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $1.11
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $3.64
Upside: -
Upgrades: Buy
Price Target: n/a
Current: $206.83
Upside: -